Showing results (11-20 of 2,946) with videos related to
Sort By:
Pageof 295
European Heart Journal|January 1, 1988
When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?W Rudolph, J Dirschinger, G Reiniger, et al.European Heart Journal|May 1, 1989
Effectiveness of interval nitrate therapy in angina pectorisW Rudolph, J Dirschinger, D Hall, et al.Zeitschrift Fur Kardiologie|January 1, 1990
Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of toleranceW Rudolph, J Dirschinger, F Kraus, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1982
Different hemodynamic response after acute diuresis in the normotensive and hypertensive stateF Charocopos, P Hatzinikolaou, D DipettiJournal of Cardiovascular Pharmacology|January 1, 1991
Efficacy and safety of ramipril in combination with hydrochlorothiazide: results of a long-term studyD Heidbreder, K L Froer, B Bauer, et al.Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Systemic and regional hemodynamic effects of propranolol in intact and anephric ratsP Hatzinikolaou, F Charocopos, I Gavras, et al.Journal De Physiologie|January 1, 1984
Regional blood flows and cardiac hemodynamics in renovascular and mineralocorticoid hypertensive ratsF Charocopos, P Hatzinikolaou, I Gavras, et al.The American Journal of Physiology|October 1, 1982
Systemic and regional hemodynamic effects of endogenous vasopressin stimulation in ratsF Charocopos, P Hatzinikolaou, W G North, et al.Clinical Cardiology|December 1, 1992
Combination of ramipril and hydrochlorothiazide in the treatment of mild to moderate hypertension: Part 1--A double-blind, comparative, multicenter study in nonresponders to ramipril monotherapyD Heidbreder, K L Froer, A Breitstadt, et al.Clinical Cardiology|January 1, 1993
Combination of ramipril and hydrochlorothiazide in the treatment of mild to moderate hypertension--Part 2: An open long-term study of efficacy and safetyD Heidbreder, K L Froer, B Bauer, et al.Pageof 295